Laxmi Organic Industries (LXCHEM) Q2 24/25 earnings summary

Executive summary

• Achieved double-digit year-over-year revenue and volume growth in Q2 FY25 and H1 FY25, despite challenging market and industry conditions.

• Growth was driven by operational excellence, capacity augmentation, and a customer-centric approach, resulting in market share gains and expansion into new industries.

• Commercial production at the Fluoro-intermediates site is expected in H2 FY25, with anticipated revenue contribution.

• Specialty chemicals business now offers over 50 products serving diverse applications.

• Dahej site project and other major capex initiatives remain on schedule and within budget, with regulatory approvals progressing.

Financial highlights

• Q2 FY25 consolidated revenue rose 18% year-over-year to INR 7,713 million; H1 FY25 revenue up 8% to INR 14,894 million.

• Q2 FY25 EBITDA increased 92% year-over-year to INR 747 million; H1 FY25 EBITDA up 25% to INR 1,459 million.

• Q2 FY25 PAT surged 162% year-over-year to INR 280 million; H1 FY25 PAT up 27% to INR 624 million.

• Gross margin for Q2 FY25 was 35.8%, up from 29.2% in Q2 last year.

• Basic EPS for H1 FY25 stood at 2.26, up from 1.85 in H1 FY24.

Outlook and guidance

• Targeting to double consolidated revenue and triple EBITDA by FY28, with a combined RoCE goal of 20%.

• Specialty fluoro intermediates expected to contribute 10-15% of peak revenues in FY25, 40-60% in FY26, and reach full peak by FY27.

• Year-on-year growth expected to continue into Q3 FY25.

• Management expects continued growth following the merger of Yellowstone Fine Chemicals Pvt Ltd, pending NCLT approval.